Screener
Kestra Medical Technologies KMTS Q4 2026 Annual earnings
Reported July 14, 2026 · After market close
Revenue$28.6MBeat by $2.2M
EPS-$0.67Miss by $0.08
Revenue estimate$26.5M
EPS estimate-$0.59
“Kestra concluded fiscal year 2026 with another strong quarter of financial performance, generating revenue growth of 66% while expanding gross margin to 55%”
Next report
Dec 10, 2026 (in 2 months)Revenue estimate$32.0M
EPS estimate-$0.61
Valuation & ratios
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Kestra Medical Technologies report Q4 2026 earnings?
- Kestra Medical Technologies (KMTS) reported Q4 2026 earnings on July 14, 2026 after market close.
- What were Kestra Medical Technologies's Q4 2026 revenue and EPS?
- Kestra Medical Technologies reported revenue of $28.6M and eps of $-0.67 for Q4 2026.
- Did Kestra Medical Technologies beat estimates in Q4 2026?
- Revenue beat the consensus estimate of $26.5M by $2.2M. EPS missed the consensus estimate of $-0.59 by $0.08.
- How did Kestra Medical Technologies's Q4 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 66.2% from $17.2M a year earlier and eps grew 36.2% from $-1.05.
- Where can I find Kestra Medical Technologies's Q4 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-303169) and the 10-K periodic report (0001193125-26-303397) directly on SEC EDGAR. The filing index links above go to sec.gov.
